Influence of electrolytes on the controlled release of verapamil hydrochloride from HPMC K15M matrix tablets

Main Article Content

Suryadevara Vidyadhara
Janga Ramesh Babu
Talamanchi Bala krishna
Talamanchi Bala krishna


Verapamil hydrochloride was formulated as oral-controlled release matrix tablets using hydrophilic polymer such as hydroxypropyl methylcellulose K15 M (HPMC 15 M) along with electrolytes. In this work a new attempt was made for in situ interactions between drug and electrolytes were devised to control the release of highly water soluble drugs from oral hydrophilic monolithic systems. Electrolytes such as aluminum hydroxide and sodium carbonate were used at different
concentrations in various formulations, while drug and polymer concentrations were maintained constantly at 1:2 ratios in all the formulations. These electrolytes were used to monitor matrix swelling and gel properties. Electrolytes at higher concentrations exhibited greater inhibition in drug release from the matrix and low concentrations were accounted for controlled release of the drug.The results indicated that the drug released at a controlled rate were due to differential swelling rate and matrix stiffening, and provides a uniform gel layer.These findings indicated that the swelling and gel formation in the
presence of ionizable species within the hydrophilic matrices provide an attractive alternative for controlled drug delivery from a simple monolithic system. Accelerated stability studies were carried out as per ICH guidelines for some selected formulations, which indicated that these formulations were stable at accelerated storage conditions.


Download data is not yet available.

Article Details

How to Cite
Vidyadhara, S., Babu, J. R., krishna, T. B., & krishna, T. B. (2014). Influence of electrolytes on the controlled release of verapamil hydrochloride from HPMC K15M matrix tablets. Asian Journal of Pharmaceutics (AJP), 5(1).


HayashidaT, Kikumaru K, Tomoyukio. US Patent No., US 1997 593 694.

Conte U, La Manna A, Maggi L. US Patent No., US 5 1997 626 874.

Fassihis R, Yang L. US Patent No., US 5 1998 783 212.

Siepmann J, Ainaouli A, Vergnaud JM, Bodmeler R. Formulation and

Evaluation of bilayered tablets of propanolol Hcl by using gums. J

Pharm SCI 1998;87:827.

Benowitz NL. Basic and clinical pharmacology. In: Katzung BG. 6th ed.

Newyork: Prentice-Hall international Inc.; 1995. p. 157.

Reynolds JE. The Extra Pharmacopeia. 30th ed. In: Martindale. London:

The Pharmaceutical Press; 2005. p. 354.

Pagay SN. The influence of Hydroalcoholic systems media on

Hypermellose matrix. Drug Develop Ind Phram 1988;14:875.

McClelland GA, Zentner GM. US patent No, US 5 1992 120 548.

Espinoza R, Hong E, Villafuerte L. Influence of admixed citric acid on

the release profile of Pelanserine Hydrochloride from HPMC matrix

tablets. Eur J Pharm Biopharm 2000;20:165-73.

Thoma K, Zimmer T. The pH independent release of Fenoldopam from

pellets with insoluble films coats. Int J Pharm 1990;58:197.

Pillay V, Fasssihi R. US patent Appl, 1998 09/037 096.

United states pharmacopeia 25. Rockville, MD; United States

pharmacopoeial convention Inc; 2007. p. 1475.

Vendruscolo CW, Andreazza IF, Ganter JI, Ferrero C, Bresolin TM,

Xanthan and galactomann from M. scabrella matrix tablets based for

oral controlled delivery of theophylline. Int J Pharm 2005;1-11 296.

Indian Pharmacopoeia. Vol. 2. Ghaziabad: The Indian Pharmacopoeial

commission; 2010. p. 177-182,207.

. Vidyadhara S, Rao PR, Prasad JA. Formulation and Evaluation of

propanolol hydrochloride oral controlled release matrix tablets. Indian

J Pharm Sci 2004;66:188-92.